PRAME induces genomic instability in uveal melanoma

PRAME is a CUL2 ubiquitin ligase subunit that is normally expressed in the testis but becomes aberrantly overexpressed in many cancer types in association with aneuploidy and metastasis. Here, we show that PRAME is expressed predominantly in spermatogonia around the time of meiotic crossing-over in...

Full description

Saved in:
Bibliographic Details
Published inOncogene Vol. 43; no. 8; pp. 555 - 565
Main Authors Kurtenbach, Stefan, Sanchez, Margaret I., Kuznetsoff, Jeffim, Rodriguez, Daniel A., Weich, Natalia, Dollar, James J., Cruz, Anthony, Kurtenbach, Sarah, Field, Matthew G., Durante, Michael A., Decatur, Christina, Sorouri, Mahsa, Lai, Fan, Yenisehirli, Gulum, Fang, Bin, Shiekhattar, Ramin, Pelaez, Daniel, Correa, Zelia M., Verdun, Ramiro E., Harbour, J. William
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 16.02.2024
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PRAME is a CUL2 ubiquitin ligase subunit that is normally expressed in the testis but becomes aberrantly overexpressed in many cancer types in association with aneuploidy and metastasis. Here, we show that PRAME is expressed predominantly in spermatogonia around the time of meiotic crossing-over in coordination with genes mediating DNA double strand break repair. Expression of PRAME in somatic cells upregulates pathways involved in meiosis, chromosome segregation and DNA repair, and it leads to increased DNA double strand breaks, telomere dysfunction and aneuploidy in neoplastic and non-neoplastic cells. This effect is mediated at least in part by ubiquitination of SMC1A and altered cohesin function. PRAME expression renders cells susceptible to inhibition of PARP1/2, suggesting increased dependence on alternative base excision repair pathways. These findings reveal a distinct oncogenic function of PRAME that can be targeted therapeutically in cancer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0950-9232
1476-5594
1476-5594
DOI:10.1038/s41388-023-02887-0